[F1Article 93 U.K. Transitional measures concerning biocidal products not covered by the scope of Directive 98/8/EC
By way of derogation from Article 17(1), a Member State may continue to apply its current system or practice of making available on the market and using a biocidal product not covered by the scope of Directive 98/8/EC, but falling within the scope of this Regulation, and consisting of, containing or generating only active substances that were available on the market, or used in biocidal products, on 1 September 2013 . The derogation shall apply until one of the following dates:
where applications for approval of all those active substances, which the biocidal product consists of, contains or generates, are submitted for the relevant product-type by 1 September 2016 , the deadlines provided for in the second subparagraph of Article 89(2), in Article 89(3) and in Article 89(4); or
where an application is not submitted in accordance with point (a) for one of the active substances, until 1 September 2017 .]
Textual Amendments
F1 Substituted by Regulation (EU) No 334/2014 of the European Parliament and of the Council of 11 March 2014 amending Regulation (EU) No 528/2012 concerning the making available on the market and use of biocidal products, with regard to certain conditions for access to the market (Text with EEA relevance).